Cite
HARVARD Citation
Raja, M. et al. (2010). Ranibizumab treatment for neovascular age-related macular degeneration in patients with good baseline visual acuity (better than 6/12): 12-month outcomes. British journal of ophthalmology. 94 (11), pp. 1543-1545. [Online].